24/7
Buzz
Startups
VC
AI
Innovation
Opinions
Events
Promising Startups 2024
BiblioTech
Boarding Pass
Corporate
Appointments
CTalk
Tech Gateways
2025 VC survey
@Finance
Ctech Testimonials
Shopping
Projects
Spotlight
About
Newsletter
Contact us
RSS
Facebook
Twitter
ACCESSIBILITY
by
Homepage
NeuroDerm
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
Innovation
OPINIONS
EVENTS
SHOPPING
ABOUT
Terms Of Use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
11:19
Why humans are the most valuable commodity in the AI talent arms race
10:52
Intel’s Israeli workforce set to fall below 9,000, its lowest in over a decade
10:25
Israeli tech's undercurrents: A special report on the employment crisis
09:46
‘This is the real long COVID’: Remote jobs, fake resumes and Soham Parekh
More stories
Buzz
Most popular
Daily
Weekly
1
How ChatGPT pinpointed Iranian missile strikes with just Google and the news
2
Remote work’s dark side: The Soham Parekh story
3
High-tech’s hidden unemployment crisis: Veteran workers hit hard
4
Fab38 freeze: Intel’s big manufacturing bet collides with harsh market reality
5
Mapping Israel’s cybersecurity ecosystem: Funding doubles despite global headwinds
More news
NeuroDerm
3 stories about NeuroDerm
After a Two-Years Slump, Israeli Tech M&A, IPOs, Up 110%
27.12.17
|
Amarelle Wenkert
U.S. buyers accounted for the majority of deals in 2017, with as many as 33 deals valued at $4.1 billion, according to a new report
Mitsubishi Tanabe Pharma Finalizes $1.1 Billion Buy of Israel-Based NeuroDerm
19.10.17
|
Lilach Baumer
NeuroDerm is looking to bring major change to Parkinson patients with its drug reformulation
Mitsubishi Tanabe Pharma to Buy Israel-Based NeuroDerm for $1.1 Billion
25.07.17
|
Gil Kalian
Osaka-based Mitsubishi Tanabe said it expects the deal would help it achieve sales of over $700 million in the U.S. by 2020